What is ApoB and why does it matter more than LDL?

ApoB counts every atherogenic lipoprotein particle that can penetrate an arterial wall, LDL, VLDL, IDL, and Lp(a), while LDL-cholesterol measures only the cholesterol content within LDL particles; ApoB predicts cardiovascular events more accurately than LDL-C because particle count (not cholesterol concentration) determines how many particles can penetrate arterial walls, and in men with metabolic syndrome or high triglycerides, LDL-C can be normal while ApoB is dangerously elevated (discordance), which standard lipid panels miss entirely (Sniderman et al., JAMA Intern Med, 2019).

The discordance problem: a man with a waist circumference of 40 inches, fasting triglycerides of 170 mg/dL, and HDL of 38 mg/dL likely has an LDL-C of 110 mg/dL (seemingly "acceptable") but ApoB of 115 mg/dL (above the guideline-recommended threshold of 80 mg/dL for average-risk men), because he has many small, dense LDL particles that carry less cholesterol each but are present in large numbers. His standard lipid panel says "borderline." His ApoB says "at risk." This gap exists in an estimated 20–25% of American men, those with the metabolic pattern that creates discordance.

Honesty Scale: Solid (1) for ApoB's superiority over LDL-C for cardiovascular risk prediction. This is supported by the evidence summary of the 2019 European Cardiovascular Prevention Guidelines and multiple JACC and JAMA papers.

What to do: Request ApoB on your next fasting lipid panel. Most laboratory panels include ApoB as an add-on at low cost ($10–$30 at most laboratory services). The target for average-risk men: below 80 mg/dL. For men with prior cardiovascular events or high risk: below 65 mg/dL.

For the full picture, read The ApoB/Lp(a)/Lipids Deep Dive